Diseases
marginal zone lymphoma
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Overview
Marginal zone lymphoma (MZL) is a group of indolent (slow growing) NHL B-cell lymphomas, which account for approximately eight percent of all NHL cases. The average age at diagnosis is 60 years, and it is slightly more common in women than in men.
Symptoms
- fever
- painless swelling of lymph nodes in your neck, armpits or groin
- persistent fatigue
Causes
- white blood cells called lymphocytes develop changes in their dna.
Risk factors
- age
- a family history of lymphoma.
Diagnosis
- blood tests.
- imaging tests.
- biopsy
Medicines used
Frequently asked questions
What is marginal zone lymphoma?
Marginal zone lymphoma (MZL) is a group of indolent (slow growing) NHL B-cell lymphomas, which account for approximately eight percent of all NHL cases. The average age at diagnosis is 60 years, and it is slightly more common in women than in men.
What are the symptoms of marginal zone lymphoma?
fever, painless swelling of lymph nodes in your neck, armpits or groin, persistent fatigue
What causes marginal zone lymphoma?
white blood cells called lymphocytes develop changes in their dna.
Which medicines are used for marginal zone lymphoma?
lenalidomide
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.